What Happened?
South San Francisco, CA-based Sonoma Biotherapeutics Appointed Heidi Hagen as Chief Technical Officer
About the Company
Sonoma Biotherapeutics is inventing the future of living therapies for autoimmune disease — safe, effective treatments as unique as each individual patient. Regulatory T cell therapies that harness a patient`s own immune cells, powerful next generation gene editing techniques and advanced manufacturing and quality assurance processes. Sonoma`s mission is to create a best-in-class regulatory T cell therapy that delivers long-lasting, highly efficacious treatments leading to cures across a spectrum of autoimmune and degenerative diseases.
About the Person
Heidi Hagen is Chief Technical Officer at Sonoma Biotherapeutics. Previously, Heidi held various senior IT leadership roles in the industry.
Info Source
News
Short Profile